Sierpiński Radosław, Sokolska Justyna M, Suchocki Tomasz, Koń Beata, Urbański Filip, Kruk Marcin, Sokolski Mateusz, Ponikowski Piotr, Jankowska Ewa A
Medical Research Agency, Warsaw, Poland.
University of Cardinal Wyszynski in Warsaw, Warsaw, Poland.
ESC Heart Fail. 2020 Dec;7(6):3365-3373. doi: 10.1002/ehf2.13060. Epub 2020 Oct 22.
Heart failure (HF) remains a major public health challenge worldwide. Contemporary epidemiological data on HF hospitalization rates and related in-hospital mortality are scarce also in Poland. The aim of the study was to determine the trends in hospitalization rates due to HF and related in-hospital mortality in Poland in the recent decade.
Data on HF hospitalizations and in-hospital mortality in patients aged >17 years in Poland between 2010 and 2019 were obtained from the central database of the Polish National Health Fund. Hospitalizations with either primary or secondary diagnosis of HF were identified using the 10th revision of the International Statistical Classification of Diseases and Related Health Problems codes (I50, I42, J81 with extensions, and R57.0). There were 4 259 698 HF hospitalizations and 608 577 in-hospital deaths (14% in-hospital mortality) reported during 2010-2019 in Poland. During this period, there was a steady increase in the number of HF hospitalizations per 1000 inhabitants in subsequent years, being more pronounced in men than in women (in 2019: 16 and 13 HF hospitalizations per 1000 inhabitants in men and women, respectively). The relative risk of HF hospitalization was higher in men than in women, and this gender-related difference steadily increased from 9% in 2010 to 25% in 2019. During 2010-2019, there was an increase in the number of HF hospitalizations per 1000 inhabitants in subsequent age groups, with a trend being more pronounced in men than in women (129 and 99 HF hospitalizations per 1000 inhabitants in men and women aged ≥80 years, respectively). During this period, there was a slight increase in in-hospital mortality during HF hospitalization in subsequent years, being more pronounced in women than in men (in 2019: 16% and 14% of in-hospital mortality in women and men, respectively). The relative risk of in-hospital mortality during HF hospitalization was higher in women than in men, and this gender-related difference steadily increased from 8% in 2010 to 18% in 2019. During this period, in-hospital mortality during HF hospitalization was ~12% for women and men aged 18-29 years, whereas the highest values of in-hospital mortality reached ~19% for patients aged ≥80 years.
We have observed steady growing trends in HF hospitalization rates and related in-hospital mortality in Poland over the last decade. Both age and gender have differentiated the reported epidemiological patterns.
心力衰竭（HF）仍是全球主要的公共卫生挑战。波兰关于HF住院率及相关院内死亡率的当代流行病学数据也很匮乏。本研究的目的是确定波兰近十年来因HF导致的住院率及相关院内死亡率的趋势。
2010年至2019年波兰17岁以上患者HF住院及院内死亡数据来自波兰国家卫生基金的中央数据库。使用《国际疾病和相关健康问题统计分类》第10版编码（I50、I42、J81及扩展编码，以及R57.0）识别HF的初次或二次诊断住院病例。2010 - 2019年波兰共报告4259698例HF住院病例和608577例院内死亡（院内死亡率14%）。在此期间，随后几年每1000名居民中HF住院病例数稳步增加，男性比女性更明显（2019年：男性和女性每1000名居民中分别有16例和13例HF住院病例）。HF住院的相对风险男性高于女性，且这种性别差异从2010年的9%稳步增加到2019年的25%。2010 - 2019年，随后各年龄组每1000名居民中HF住院病例数增加，男性比女性趋势更明显（≥80岁男性和女性每1000名居民中分别有129例和99例HF住院病例）。在此期间，随后几年HF住院期间的院内死亡率略有增加，女性比男性更明显（2019年：女性和男性院内死亡率分别为16%和14%）。HF住院期间院内死亡的相对风险女性高于男性，且这种性别差异从2010年的8%稳步增加到2019年的18%。在此期间，18 - 29岁女性和男性HF住院期间的院内死亡率约为12%，而≥80岁患者的院内死亡率最高达到约19%。
我们观察到波兰在过去十年中HF住院率及相关院内死亡率呈稳步上升趋势。年龄和性别均使报告的流行病学模式有所不同。
